{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T13:20:23Z","timestamp":1761312023990,"version":"build-2065373602"},"reference-count":12,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":378,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jacc.2023.12.003","type":"journal-article","created":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T14:01:00Z","timestamp":1707141660000},"page":"679-681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Thrombosis, Bleeding, and the Promise of\u00a0Factor XI(a) Inhibition"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1456-6430","authenticated-orcid":false,"given":"Felicita","family":"Andreotti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Massetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Montalescot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2023.12.003_bib1","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1055\/s-0040-1710013","article-title":"Role of factor XIa and plasma kallikrein in arterial and venous thrombosis","volume":"120","author":"Visser","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2023.12.003_bib2","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1182\/blood-2007-10-120139","article-title":"Reduced incidence of ischemic stroke in patients with severe factor XI deficiency","volume":"111","author":"Salomon","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2023.12.003_bib3","doi-asserted-by":"crossref","first-page":"12203","DOI":"10.1021\/acs.jmedchem.3c00795","article-title":"Design and preclinical characterization program toward asundexian (BAY 2433334), an oral factor XIa inhibitor for the prevention and treatment of thromboembolic disorders","volume":"66","author":"Roehrig","year":"2023","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.jacc.2023.12.003_bib4","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(96)11189-2","article-title":"Tissue-factor antigen and activity in human coronary atherosclerotic plaques","volume":"349","author":"Ardissino","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.12.003_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2023.101119","article-title":"Factor XI inhibitors for the prevention of cardiovascular disease: a new therapeutic approach on the horizon?","volume":"62","author":"Santagata","year":"2023","journal-title":"Blood Rev"},{"key":"10.1016\/j.jacc.2023.12.003_bib6","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1161\/01.CIR.0000160361.73423.23","article-title":"Atherothrombotic disorders: new insights from hematology","volume":"111","author":"Andreotti","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.12.003_bib7","first-page":"69","article-title":"Development of new anticoagulants in 2023: prime time for anti-factor XI and XIa inhibitors","volume":"48","author":"Bentounes","year":"2023","journal-title":"J\u00a0Med Vasc"},{"key":"10.1016\/j.jacc.2023.12.003_bib8","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1111\/jth.15890","article-title":"Achieving higher efficacy without compromising safety with factor XI inhibitors versus low molecular weight heparin for the prevention of venous thromboembolism in major orthopedic surgery: systematic review and meta-analysis","volume":"20","author":"Presume","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6","key":"10.1016\/j.jacc.2023.12.003_bib9","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jacc.2023.12.004","article-title":"Bleeding outcomes in patients treated with asundexian in phase II trials","volume":"83","author":"Eikelboom","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.12.003_bib10","doi-asserted-by":"crossref","unstructured":"Balali P, Hart RG, Smith EE, et\u00a0al. Cerebral microbleeds and asundexian in non-cardioembolic ischemic stroke: secondary analyses of the PACIFIC-STROKE randomized trial. Int J Stroke. Published online November 10,\u00a02023.","DOI":"10.1177\/17474930231216339"},{"key":"10.1016\/j.jacc.2023.12.003_bib11","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1538-7836.2012.04653.x","article-title":"Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders","volume":"10","author":"Peyvandi","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"author":"Bayer","key":"10.1016\/j.jacc.2023.12.003_bib12"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109723081986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109723081986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T14:01:35Z","timestamp":1760018495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109723081986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0735109723081986"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2023.12.003","relation":{},"ISSN":["0735-1097"],"issn-type":[{"type":"print","value":"0735-1097"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombosis, Bleeding, and the Promise of\u00a0Factor XI(a) Inhibition","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2023.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2023.12.004","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}